Correlation Between ImmuCell and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Protalix Biotherapeutics, you can compare the effects of market volatilities on ImmuCell and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Protalix Biotherapeutics.
Diversification Opportunities for ImmuCell and Protalix Biotherapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ImmuCell and Protalix is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of ImmuCell i.e., ImmuCell and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between ImmuCell and Protalix Biotherapeutics
Given the investment horizon of 90 days ImmuCell is expected to under-perform the Protalix Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ImmuCell is 1.52 times less risky than Protalix Biotherapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Protalix Biotherapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Protalix Biotherapeutics on August 30, 2024 and sell it today you would earn a total of 52.00 from holding Protalix Biotherapeutics or generate 44.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
ImmuCell vs. Protalix Biotherapeutics
Performance |
| Timeline |
| ImmuCell |
| Protalix Biotherapeutics |
ImmuCell and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmuCell and Protalix Biotherapeutics
The main advantage of trading using opposite ImmuCell and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| ImmuCell vs. Transgene SA | ImmuCell vs. Alpha Cognition | ImmuCell vs. Fennec Pharmaceuticals | ImmuCell vs. Lipella Pharmaceuticals Common |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |